Accelerated partial breast irradiation was designed to be a faster, more convenient and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning after ...
Oct 9, 2015
0
11
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.
Sep 30, 2015
0
8
More than one-third of counties in the Unites States are located more than 50 miles from the nearest gynecologic oncologist, making access to specialty care for ovarian and other gynecologic cancers difficult for nearly 15 ...
Jun 11, 2015
0
284
(HealthDay)—For breast and colorectal cancer survivors, the level of exercise participation is significantly increased for those receiving an oncologist's exercise recommendations with an exercise motivation package, according ...
May 20, 2015
0
16
Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman's tumor and extend the time period between initial ...
Mar 30, 2015
0
52
(HealthDay)—For occupational groups in cancer care, radiation therapists (RTs) have higher mean scores for stressors and coping strategies than oncology nurses (ONs), according to a study published in the December issue ...
Jan 21, 2015
0
7
Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because ...
Jan 5, 2015
0
13
(HealthDay)—Despite concerns about potentially dangerous interactions between cancer treatments and herbs and other supplements, most cancer doctors don't talk to their patients about these products, new research found.
Jan 5, 2015
0
60
(HealthDay)—For women who have ductal carcinoma in situ surgically removed, a genetic test may help predict the odds of a recurrence, according to research presented at the annual San Antonio Breast Cancer Symposium, held ...
Dec 14, 2014
0
0
Use of anthracycline-based chemotherapy, a common treatment for breast cancer, has negligible cardiac toxicity in women whose tumors have BRCA1/2 mutations—despite preclinical evidence that such treatment can damage the ...
Dec 9, 2014
0
0
